Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil

NCT01965925 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: Modafinil
DRUG: Placebo

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]